Discounted Cash Flow
Core Scientific, Inc./Tx
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2020 | $60.3m | $-12.2m | $-43.6m | -20.2% | $-0.14 |
| 2021 | $544.5m (802.7%) | $-32.5m (-166.3%) | $-1.9m (95.7%) | -6.0% (70.5%) | $0.23 (264.3%) |
| 2022 | $640.3m (17.6%) | $-2.1b (-6504.3%) | $205.2m (11064.0%) | -335.2% (-5515.9%) | $-6.30 (-2839.1%) |
| 2023 | $502.4m (-21.5%) | $-246.5m (88.5%) | $65.1m (-68.3%) | -49.1% (85.4%) | $-0.65 (89.7%) |
| 2024 | $510.7m (1.6%) | $-1.3b (-433.5%) | $-80.0m (-222.8%) | -257.5% (-424.9%) | $-4.39 (-575.4%) |
| 2025 | $319.0m (-37.5%) | $-288.6m (78.1%) | $266.9m (433.7%) | -90.5% (64.9%) | $-0.88 (80.0%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.